Beyer Mandy, Kiweler Nicole, Mahboobi Siavosh, Krämer Oliver H
Institute of Toxicology, University Medical Center Mainz, Mainz, 55131, Germany.
Faculty of Chemistry and Pharmacy, Institute of Pharmacy, University of Regensburg, Regensburg, 93040, Germany.
Methods Mol Biol. 2017;1510:355-364. doi: 10.1007/978-1-4939-6527-4_26.
Histone deacetylases (HDACs) catalyze the deacetylation of lysine residues in their target proteins. This biochemical modification can have profound effects on the functions of these proteins and a dysregulation of HDAC activity contributes to severe diseases, including neoplastic transformation. In the following chapter, we present a strategy that allows to distinguish between the inhibition of the class I HDACs HDAC1, 2, and 3 and of the class IIb HDAC HDAC6. This method is based on Western blot and relies on the detection of hyperacetylated substrates of class I or class IIb HDACs in lysates from cells that were treated with histone deacetylase inhibitors (HDACi).
组蛋白去乙酰化酶(HDACs)催化其靶蛋白中赖氨酸残基的去乙酰化反应。这种生化修饰可对这些蛋白质的功能产生深远影响,而HDAC活性的失调会导致包括肿瘤转化在内的严重疾病。在接下来的章节中,我们将介绍一种策略,该策略能够区分I类HDACs(HDAC1、2和3)和IIb类HDAC(HDAC6)的抑制作用。此方法基于蛋白质免疫印迹法,依赖于在经组蛋白去乙酰化酶抑制剂(HDACi)处理的细胞裂解物中检测I类或IIb类HDACs的高乙酰化底物。